Citigroup
IDXG

Citigroup’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Citigroup’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5
Closed – – 7588
2017
Q1 		$0 Hold
5
– – ﹤0.01% 7430
2016
Q4 		$0 Buy
5
+3
+150% +$96 ﹤0.01% 7415
2016
Q3 		$0 Buy
+2
New +$55 ﹤0.01% 7279
2015
Q3 		– Sell
-1
Closed – – 7947
2015
Q2 		$0 Buy
+1
New +$139 ﹤0.01% 7892
2014
Q3 		– Sell
-1
Closed – – 7423
2014
Q2 		$0 Buy
+1
New +$461 ﹤0.01% 7425
2013
Q4 		– Hold
0
– – – 7233
2013
Q3 		– Hold
0
– – – 7089

Other funds holding IDXG

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return